Compare Bangun Kosambi Sukses Tbk. (CBDK) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bangun Kosambi Sukses Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bangun Kosambi Sukses Tbk. trades at Rp3,500 (market cap 19.84T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Bangun Kosambi Sukses Tbk. is far larger — about 118.5× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| CBDK | OBAT | |
|---|---|---|
Market Cap | 19.84T | 167.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bangun Kosambi Sukses Tbk.
PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.
Read more on CBDK →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
